News and views for the UB community
Jonathan Lovell is leading a research team that's developing a novel immunotherapy approach to Alzheimer's treatment.
New School of Management research reveals unintended costs of the SEC's EDGAR database.
UB will host scholars from underrepresented backgrounds and provide expertise in hydrogen fuel production.
A total of $200,000 in funding has been awarded to four cross-disciplinary projects in the first round of awards.
New School of Management research provides a framework for understanding flexible thinking.
A new research framework developed by UB researchers will help AI chatbots better mimic human conversation.
With support from a $2.5 million NIH grant, UB chemist David Heppner is trying to answer key questions about the time-consuming and costly drug discovery process.
The Templeton Foundation is funding the innovative project that will show how diversity, disagreement and dynamism are crucial for an open society.
UB expert Dominic Sellitto says businesses should check widely deployed software and make sure auto-updates are kept to a minimum.
A $4 million NIH grant awarded to UB researchers will support work to overcome the growing number of health care infections.
A UB study has found patients were more likely to stick with treatment if referred through telemedicine vs. the emergency department.